The value of observational research in liver diseases^†

• Pages: 1-3
• First Published: 19 November 2010

What goes up must come down: The emerging role of microRNA in fibrosis^†‡

• Pages: 4-6
• First Published: 12 November 2010

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients^†

• Pages: 7-13
• First Published: 10 September 2010

Quantitation of pretreatment serum interferon-γ–inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response^†‡

• Pages: 14-22
• First Published: 26 October 2010

Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10^†

• Pages: 23-31
• First Published: 14 September 2010

Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models^†

• Pages: 32-41
• First Published: 14 September 2010

Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection^†

• Pages: 42-52
• First Published: 06 October 2010

MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes^†

• Pages: 53-61
• First Published: 30 September 2010

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease^†

• Pages: 62-72
• First Published: 01 September 2010

Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients^†

• Pages: 73-85
• First Published: 10 September 2010

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians^†‡§

• Pages: 86-95
• First Published: 30 September 2010

Enteric dysbiosis associated with a mouse model of alcoholic liver disease^†‡

• Pages: 96-105
• First Published: 30 September 2010

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis^†

• Pages: 106-115
• First Published: 20 September 2010

Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning^†‡

• Pages: 116-126
• First Published: 24 September 2010

C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen-activated protein kinases^†‡

• Pages: 127-135
• First Published: 24 September 2010

Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study^{† ‡}

• Pages: 136-147
• First Published: 07 September 2010

Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells^†

• Pages: 148-159
• First Published: 07 September 2010

Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation^†

• Pages: 160-170
• First Published: 20 September 2010

Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1α pre-mRNA in mice and in vitro^†‡

• Pages: 171-180
• First Published: 24 September 2010

p28^GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways^†

• Pages: 181-192
• First Published: 30 September 2010

Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy^†

• Pages: 193-201
• First Published: 30 September 2010

Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in taiwan^†‡§

• Pages: 202-208
• First Published: 06 October 2010

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis^†‡

• Pages: 209-218
• First Published: 20 August 2010

Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells^†

• Pages: 219-229
• First Published: 14 September 2010

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells^†‡

• Pages: 230-242
• First Published: 20 September 2010

Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury^†

• Pages: 243-252
• First Published: 10 September 2010

Activation of serotonin receptor-2B rescues small-for-size liver graft failure in mice^†

• Pages: 253-262
• First Published: 07 September 2010

CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury^†

• Pages: 261-271
• First Published: 06 October 2010

Organic anion–transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice^†‡

• Pages: 272-281
• First Published: 14 September 2010

Tumor necrosis factor α sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner^†

• Pages: 282-292
• First Published: 24 September 2010

Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds^†‡§

• Pages: 293-305
• First Published: 24 September 2010

Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β^†‡

• Pages: 306-316
• First Published: 06 October 2010

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection^†

• Pages: 317-324
• First Published: 12 November 2010

Noninvasive assessment of liver fibrosis^†

• Pages: 325-335
• First Published: 30 September 2010

Hepatitis C pharmacogenetics: State of the art in 2010^†‡§

• Pages: 336-345
• First Published: 26 October 2010

Endocannabinoids in liver disease^†

• Pages: 346-355
• First Published: 18 November 2010

Controlling autophagy: A new concept for clearing liver disease^†

• Pages: 356-358
• First Published: 12 January 2011

Identifying who is at risk of drug-induced liver injury: Is human leukocyte antigen specificity the key?^†

• Pages: 358-362
• First Published: 19 January 2011

The genetics of primary biliary cirrhosis: The revolution moves on^†

• Pages: 362-364
• First Published: 12 January 2011

Digital clubbing in association with hepatopulmonary syndrome^†

• Pages: 365-366
• First Published: 20 August 2010

Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients^†

• Pages: 367-368
• First Published: 04 November 2010

Reply:^†‡

• Page: 368
• First Published: 04 November 2010

Hyponatremia in patients treated with terlipressin: Mechanisms and implications for clinical practice^†

• Pages: 368-369
• First Published: 04 November 2010

Reply^†

• Pages: 369-370
• First Published: 09 December 2010

Drug-induced autoimmune hepatitis: An easily reversible type of liver fibrosis?^†

• Page: 370
• First Published: 12 January 2011

Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?^†

• Pages: 370-371
• First Published: 12 January 2011

The deleterious effects of propranolol on patients with cirrhosis^†

• Pages: 371-372
• First Published: 12 January 2011

Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis1

• Pages: 372-373
• First Published: 12 January 2011

Tea intake and liver diseases^†

• Pages: 373-374
• First Published: 12 January 2011

Hepatectomy versus radiofrequency ablation for early-stage hepatocellular carcinoma1

• Page: 374
• First Published: 31 August 2010

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease^†

• Page: 375
• First Published: 19 August 2010

Combinative strategy using tamoxifen and other chemotherapeutic drugs for cholangiocarcinoma chemotherapy^†

• Pages: 375-376
• First Published: 18 August 2010

• Page: 377
• First Published: 12 January 2011

• Page: 377
• First Published: 12 January 2011